EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY-NC-ND 4.0

Pharmacologic interventions for the treatment of equine herpesvirus-1 in domesticated horses: A systematic review

Lutz Goehring iD, David C Dorman iD, Klaus Osterrieder iD, Brandy A Burgess iD, Kelsie Dougherty, Peggy Gross iD, Claire Neinast, Nicola Pusterla, Gisela Soboll-Hussey iD, David P Lunn iD

Journal of Veterinary Internal Medicine · 01.05.2024 · 38 (3) · 1892-1905

DOI: 10.1111/jvim.17016 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Journal of Veterinary Internal Medicine, online erschienen am 01.05.2024. Verfasst von Lutz Goehring und 9 weiteren Autor:innen. Beteiligte Einrichtung: University of Kentucky, College of Agriculture, Food and Environment, Maxwell H. Gluck Equine Research Center, 1400 Nicholasville Road, Lexington, Ke…. Hauptthemen laut MEDLINE: Herpesvirus 1, Equid, Horse Diseases, Herpesviridae Infections, Antiviral Agents. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Equine herpes virus type 1 (EHV-1) infection in horses is associated with upper respiratory disease, neurological disease, abortions, and neonatal death. Review Question Does pharmacological therapy decrease either the incidence or severity of disease or infection caused by EHV-1 in domesticated horses?

Methods

A systematic review was preformed searching AGRICOLA, CAB Abstracts, Cochrane, PubMed, Web of Science, and WHO Global Health Index Medicus Regional Databases to identify articles published before February 15, 2021. Selection criteria were original research reports published in peer reviewed journals, and studies investigating in vivo use of therapeutic agents for prevention or treatment of EHV-1 in horses. Outcomes assessed included measures related to clinical outcomes that reflect symptomatic EHV-1 infection or virus infection. We evaluated risk of bias and performed a GRADE evaluation of the quality of evidence for interventions.

Results

A total of 7009 unique studies were identified, of which 9 met the inclusion criteria. Two studies evaluated valacyclovir or small interfering RNAs, and single studies evaluated the use of a Parapoxvirus ovis-based immunomodulator, human alpha interferon, an herbal supplement, a cytosine analog, and heparin. The level of evidence ranged between randomized controlled studies and observational trials. The risk of bias was moderate to high and sample sizes were small. Most studies reported either no benefit or minimal efficacy of the intervention tested. Conclusions and Clinical Importance Our review indicates minimal or limited benefit either as a prophylactic or post-exposure treatment for any of the studied interventions in the mitigation of EHV-1-associated disease outcome.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Herpesvirus 1, EquidHorse DiseasesHerpesviridae InfectionsAntiviral AgentsAnimalsHorsesValacyclovir

Stichwörter der Autor:innen

chemotherapyequineequine herpesvirus myeloencephalopathyherpesvirus‐1

Substanzen

Antiviral AgentsValacyclovir

Autor:innen und Institutionen

  • University of Kentucky, College of Agriculture, Food and Environment, Maxwell H. Gluck Equine Research Center, 1400 Nicholasville Road, Lexington, Kentucky 40546-0099, USA.
  • College of Veterinary Medicine, North Carolina State University, 1060 William Moore Drive, Raleigh, North Carolina 27607, USA.
  • Institut für Virologie, Freie Universität Berlin, Robert-von-Ostertag-Str. 7, 14163 Berlin, Germany.
  • College of Veterinary Medicine, University of Georgia, 2200 College Station Road, Athens, Georgia 30602, USA.
  • School of Veterinary Medicine, University of California, Davis, One Garrod Drive, Davis, California 95616, USA.
  • College of Veterinary Medicine, Michigan State University, Veterinary Medical Center, Room G331, 784 Wilson Road, East Lansing, Michigan 48824, USA.

ORCID-Profile: Lutz Goehring, David C Dorman, Klaus Osterrieder, Brandy A Burgess, Peggy Gross, Gisela Soboll-Hussey, David P Lunn

Zitieren

APA

Goehring, L., Dorman, D. C., Osterrieder, K., Burgess, B. A., Dougherty, K., Gross, P., Neinast, C., Pusterla, N., Soboll-Hussey, G., & Lunn, D. P. (2024). Pharmacologic interventions for the treatment of equine herpesvirus-1 in domesticated horses: A systematic review. Journal of Veterinary Internal Medicine, 38(3), 1892-1905. https://doi.org/10.1111/jvim.17016

Vancouver

Goehring L, Dorman DC, Osterrieder K, Burgess BA, Dougherty K, Gross P, et al. Pharmacologic interventions for the treatment of equine herpesvirus-1 in domesticated horses: A systematic review. Journal of Veterinary Internal Medicine. 2024;38(3):1892-1905. doi:10.1111/jvim.17016

BibTeX
@article{Goehring2024,
  author = {Goehring, Lutz and Dorman, David C and Osterrieder, Klaus and Burgess, Brandy A and Dougherty, Kelsie and Gross, Peggy and Neinast, Claire and Pusterla, Nicola and Soboll-Hussey, Gisela and Lunn, David P},
  title = {Pharmacologic interventions for the treatment of equine herpesvirus-1 in domesticated horses: A systematic review},
  journal = {Journal of Veterinary Internal Medicine},
  year = {2024},
  volume = {38},
  number = {3},
  pages = {1892--1905},
  doi = {10.1111/jvim.17016}
}
Kostenlos starten →